Literature DB >> 19254842

Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.

Huan-Zhang Xie1, Lin-Li Li, Ji-Xia Ren, Jun Zou, Li Yang, Yu-Quan Wei, Sheng-Yong Yang.   

Abstract

In this investigation, chemical features based 3D pharmacophore models were developed based on the known inhibitors of Spleen tyrosine kinase (Syk) with the aid of hiphop and hyporefine modules within catalyst. The best quantitative pharmacophore model, Hypo1, was used as a 3D structural query for retrieving potential inhibitors from chemical databases including Specs, NCI, MayBridge, and Chinese Nature Product Database (CNPD). The hit compounds were subsequently subjected to filtering by Lipinski's rule of five and docking studies to refine the retrieved hits. Finally 30 compounds were selected from the top ranked hit compounds and conducted an in vitro kinase inhibitory assay. Six compounds showed a good inhibitory potency against Syk, which have been selected for further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254842     DOI: 10.1016/j.bmcl.2009.02.049

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors.

Authors:  Julio Caballero; Miguel Quiliano; Jans H Alzate-Morales; Mirko Zimic; Eric Deharo
Journal:  J Comput Aided Mol Des       Date:  2011-04-13       Impact factor: 3.686

2.  Investigation of the structure requirement for 5-HT₆ binding affinity of arylsulfonyl derivatives: a computational study.

Authors:  Ming Hao; Yan Li; Hanqing Li; Shuwei Zhang
Journal:  Int J Mol Sci       Date:  2011-08-08       Impact factor: 5.923

3.  Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches.

Authors:  Sathya Babu; Santhosh Kumar Nagarajan; Sruthy Sathish; Vir Singh Negi; Honglae Sohn; Thirumurthy Madhavan
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

Review 4.  Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity.

Authors:  Wiesław Szeja; Grzegorz Grynkiewicz; Aleksandra Rusin
Journal:  Curr Org Chem       Date:  2017-01       Impact factor: 2.180

5.  A general synthetic procedure for 2-chloromethyl-4(3H)-quinazolinone derivatives and their utilization in the preparation of novel anticancer agents with 4-anilinoquinazoline scaffolds.

Authors:  Hong-Ze Li; Hai-Yun He; Yuan-Yuan Han; Xin Gu; Lin He; Qing-Rong Qi; Ying-Lan Zhao; Li Yang
Journal:  Molecules       Date:  2010-12-22       Impact factor: 4.411

6.  Novel pyrazolo[3,4-d]pyrimidine derivatives as potential antitumor agents: exploratory synthesis, preliminary structure-activity relationships, and in vitro biological evaluation.

Authors:  Hai-Yun He; Jin-Ni Zhao; Ruo Jia; Ying-Lan Zhao; Sheng-Yong Yang; Luo-Ting Yu; Li Yang
Journal:  Molecules       Date:  2011-12-20       Impact factor: 4.411

7.  Prospecting for novel plant-derived molecules of Rauvolfia serpentina as inhibitors of Aldose Reductase, a potent drug target for diabetes and its complications.

Authors:  Shivalika Pathania; Vinay Randhawa; Ganesh Bagler
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.